270 Developing placental CD34+-derived natural killer cells with high affinity and cleavage resistant CD16 (CYNK-101) in combination with avelumab for enhanced therapy against PD-L1+solid tumors

Autor:	Irene Raitman, Gavin Foley, Eric He, Hemlata Rana, Niranjan Ghimire, Xuan Guo, Robert Hariri, Lin Kang
Rok vydání:	2022
Zdroj:	Regular and Young Investigator Award Abstracts.
DOI:	10.1136/jitc-2022-sitc2022.0270
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5f2415f85d06c2d5cc6581010237c285 https://doi.org/10.1136/jitc-2022-sitc2022.0270 Zobrazit plný text záznamu